Back to Carlyle Group Inc. Carlyle Group Inc.

TORCNTORCN

Showing 6 of 12 quarters

Position history for Carlyle Group Inc.Carlyle Group Inc.'s holdings in ADICET BIO INC

As of its Q3 2025 13F, Carlyle Group held 2,948,718 shares of TORCN (Adicet Bio), worth $2.4M. Carlyle Group's 13F filings listed TORCN from Q1 2023 to Q3 2025, 11 quarterly filings. TORCN was 0.1% of Carlyle Group's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$4.2M

Total Shares Change

-2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q3
Unchanged
2.9M
0.0%
$2.4M0.1%—
0
2025-Q2
Unchanged
2.9M
0.0%
$1.8M0.0%—
0
2025-Q1
Unchanged
2.9M
0.0%
$2.3M0.1%—
0
2024-Q4
Unchanged
2.9M
0.0%
$2.8M0.1%—
0
2024-Q3
Unchanged
2.9M
0.0%
$4.2M0.4%—
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used